Novavax NanoFlu™ Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu Vaccine

Go back to Novavax NanoFlu™ Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu Vaccine
Novavax, Inc. (NASDAQ: NVAX) Delayed: 9.13 -0.37 (3.89%)
Previous Close $9.50    52 Week High $9.23 
Open $9.68    52 Week Low $1.16 
Day High $9.99    P/E N/A 
Day Low $9.08    EPS $-0.30 
Volume 9,458,295       

Novavax, Inc. (NASDAQ: NVAX) Delayed: 9.13 -0.37 (3.89%)
Previous Close $9.50    52 Week High $9.23 
Open $9.68    52 Week Low $1.16 
Day High $9.99    P/E N/A 
Day Low $9.08    EPS $-0.30 
Volume 9,458,295